Why haven’t I heard more about Zeaxanthin?
There is a growing awareness of zeaxanthin because of many scientific studies and a landmark clinical trial knows as AREDS. (Age Related Eye Disorder Study) In the AREDS trial investigators concluded that a combination of relatively high doses of antioxidants, plus zinc and copper decreased macular degeneration progression by 25% in people with a high risk of developing advanced stages of the disease. The implications are striking as noted by Dr. Bressler: “If the 1.2 million U.S. citizens who will likely develop advanced age-related macular degeneration over the next five years took these supplements, (the vision of) more than 300,000 would be spared.” The National Eye Institute (NEI) strongly endorses the use of supplements containing antioxidants for advanced macular degeneration sufferers. The AREDS II trial is now underway and the protocol involves the use of the carotenoids lutein and zeaxanthin. Zeaxanthin and lutein were not commercially available when the initial AREDS study w
Related Questions
- We heard that nonprofits might be eligible to receive an extra donation of Microsoft products this year, instead of one. How does that work?
- I heard about a unique fan hospitality area where guests can hear from their favorite drivers. What is this area and where will it be?
- How is Access Data Backup different from other offsite backup services Ive heard about?
